Mary F Barbe1, Mamta Amin1, Anne Gingery2, Alex G Lambi3, Steven N Popoff1. 1. Department of Anatomy & Cell Biology, Lewis Katz School of Medicine, Temple University , Philadelphia, PA, USA. 2. Department of Orthopedic Surgery, Indiana University School of Medicine , Indianapolis, IN, USA. 3. Division of Plastic & Reconstructive Surgery, University of California, Los Angeles David Geffen School of Medicine , Los Angeles, CA, USA.
Abstract
Purpose/Aim: We recently found that blocking CCN2 signaling using a monoclonal antibody (FG-3019) may be a novel therapeutic strategy for reducing overuse-induced tissue fibrosis. Since CCN2 plays roles in osteoclastogenesis, and persistent performance of a high repetition high force (HRHF) lever pulling task results in a loss in trabecular bone volume in the radius, we examined here whether blocking CCN2 signaling would reduce the early catabolic effects of performing a HRHF task for 3 weeks. Materials and Methods: Young adult, female, Sprague-Dawley rats were operantly shaped to learn to pull at high force levels, before performing the HRHF task for 3 weeks. HRHF task rats were then left untreated (HRHF Untreated), treated in task weeks 2 and 3 with a monoclonal antibody that antagonizes CCN2 (HRHF+FG-3019), or treated with an IgG (HRHF+IgG), while continuing to perform the task. Non-task control rats were left untreated. Results: In metaphyseal trabeculae of the distal radius, HRHF Untreated and HRHF-IgG rats showed increased osteoblast numbers and other indices of bone formation, compared to controls, yet decreased trabecular bone volume, increased osteoclast numbers, and increased serum CTX-1 (a serum biomarker of bone resorption). HRHF+FG-3019 rats also showed increased osteoblast numbers and bone formation, but in contrast to HRHF Untreated and HRHF-IgG rats, showed higher trabecular bone volume, and reduced osteoclast numbers and serum CTX-1 levels (and statistically similar to Control levels). Conclusions: HRHF loading increased bone formation in each task group, yet blocking CCN2 dampened trabecular bone catabolism by reducing osteoclast numbers and activity.
Purpose/Aim: We recently found that blocking CCN2 signaling using a monoclonal antibody (FG-3019) may be a novel therapeutic strategy for reducing overuse-induced tissue fibrosis. Since CCN2 plays roles in osteoclastogenesis, and persistent performance of a high repetition high force (HRHF) lever pulling task results in a loss in trabecular bone volume in the radius, we examined here whether blocking CCN2 signaling would reduce the early catabolic effects of performing a HRHF task for 3 weeks. Materials and Methods: Young adult, female, Sprague-Dawley rats were operantly shaped to learn to pull at high force levels, before performing the HRHF task for 3 weeks. HRHF task rats were then left untreated (HRHF Untreated), treated in task weeks 2 and 3 with a monoclonal antibody that antagonizes CCN2 (HRHF+FG-3019), or treated with an IgG (HRHF+IgG), while continuing to perform the task. Non-task control rats were left untreated. Results: In metaphyseal trabeculae of the distal radius, HRHF Untreated and HRHF-IgG rats showed increased osteoblast numbers and other indices of bone formation, compared to controls, yet decreased trabecular bone volume, increased osteoclast numbers, and increased serum CTX-1 (a serum biomarker of bone resorption). HRHF+FG-3019 rats also showed increased osteoblast numbers and bone formation, but in contrast to HRHF Untreated and HRHF-IgG rats, showed higher trabecular bone volume, and reduced osteoclast numbers and serum CTX-1 levels (and statistically similar to Control levels). Conclusions: HRHF loading increased bone formation in each task group, yet blocking CCN2 dampened trabecular bone catabolism by reducing osteoclast numbers and activity.
Authors: Vicky S Massicotte; Nagat Frara; Michele Y Harris; Mamta Amin; Christine K Wade; Steven N Popoff; Mary F Barbe Journal: Exp Gerontol Date: 2015-10-27 Impact factor: 4.032
Authors: N X Jain; A E Barr-Gillespie; B D Clark; D M Kietrys; C K Wade; J Litvin; S N Popoff; M F Barbe Journal: J Musculoskelet Neuronal Interact Date: 2014-03 Impact factor: 2.041
Authors: Fayez F Safadi; Jie Xu; Steven L Smock; Reem A Kanaan; Abdul-Hafez Selim; Paul R Odgren; Sandy C Marks; Thomas A Owen; Steven N Popoff Journal: J Cell Physiol Date: 2003-07 Impact factor: 6.384
Authors: Jane M Fedorczyk; Ann E Barr; Shobha Rani; Helen G Gao; Mamta Amin; Shreya Amin; Judith Litvin; Mary F Barbe Journal: J Orthop Res Date: 2010-03 Impact factor: 3.494
Authors: Mary F Barbe; Brendan A Hilliard; Mamta Amin; Michele Y Harris; Lucas J Hobson; Geneva E Cruz; Steven N Popoff Journal: FASEB J Date: 2020-03-29 Impact factor: 5.191
Authors: Mary F Barbe; Mamta Amin; Michele Y Harris; Siva Tejaa Panibatla; Soroush Assari; Steven N Popoff; Geoffrey M Bove Journal: Int J Mol Sci Date: 2022-06-13 Impact factor: 6.208